UNUSUAL EVOLUTION: PROGRESSIVE DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOUR WITH ATYPICAL CONTRAST ENHANCEMENT AND MR SPECTROSCOPY ABNORMALITIES- A 10-YEAR FOLLOW-UP CASE REPORT

Abstract AIMS Dysembryoplastic neuroepithelial tumours (DNETs) are benign, slow-growing glial-neuronal tumours in chil- dren. Treatment includes surveillance and follow-up or surgical excision. DNETs do not typically demonstrate contrast enhancement on MRI. We describe a rare unusual radiological progression of a DNET case over a 10 year period. METHODS We present a 21-year-old female who was initially diagnosed with a left occipital DNET based on typical imaging findings and clinical presentation, when she had her first seizure at age of 11. RESULTS Over 10 years, the tumour remained stable on MRI, and seizures were well-controlled with Levetiracetam. Initial imaging in 2014 revealed a left occipital lesion with typical DNET characteristics: high T2 signal, low T1 signal, and no contrast enhancement. Annual surveillance MRIs from 2014 to 2022 showed no significant changes. However, the 2024 MRI demonstrated lesion progression, with irregular contrast enhancement, in- creased choline, reduced NAA and creatine, and a lactate peak on MR spectroscopy. Diffusion tensor imag- ing (DTI) revealed disruption of white matter tracts, further suggesting atypical behaviour. This concerning and atypical behaviour made us consider the possibility of an initial low-grade-glioma undergoing a malignant transformation. A gross total resection was achieved and histopathological and molecular analyses confirmed a benign DNET without BRAF, IDH1/IDH2 mutations, or MGMT promoter hyper methylation. CONCLUSION This case highlights the diagnostic challenges posed by DNETs with atypical imaging features, including con- trast enhancement and metabolic changes, which can mimic a high-grade transformation. Whilst advanced imaging techniques, such as MR spectroscopy, are critical in monitoring these tumours, this case underscores that current modalities are still not conclusive in defining tumour histology and warrant further radio-genomic research. Surgical resection not only provides definitive diagnosis but also guides long-term management in cases of radiological uncertainty.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-09-01
DOI
https://doi.org/10.1093/neuonc/noaf185.118
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

UNUSUAL EVOLUTION: PROGRESSIVE DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOUR WITH ATYPICAL CONTRAST ENHANCEMENT AND MR SPECTROSCOPY ABNORMALITIES- A 10-YEAR FOLLOW-UP CASE REPORT

Edward J. St. George, Ahmed Elbelkasy
Neuro-Oncology
Metabolism and Genetic Disorders
article

UNUSUAL EVOLUTION: PROGRESSIVE DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOUR WITH ATYPICAL CONTRAST ENHANCEMENT AND MR SPECTROSCOPY ABNORMALITIES- A 10-YEAR FOLLOW-UP CASE REPORT

Edward J. St. George, Ahmed Elbelkasy
article en

Abstract

Abstract AIMS Dysembryoplastic neuroepithelial tumours (DNETs) are benign, slow-growing glial-neuronal tumours in chil- dren. Treatment includes surveillance and follow-up or surgical excision. DNETs do not typically demonstrate contrast enhancement on MRI. We describe a rare unusual radiological progression of a DNET case over a 10 year period. METHODS We present a 21-year-old female who was initially diagnosed with a left occipital DNET based on typical imaging findings and clinical presentation, when she had her first seizure at age of 11. RESULTS Over 10 years, the tumour remained stable on MRI, and seizures were well-controlled with Levetiracetam. Initial imaging in 2014 revealed a left occipital lesion with typical DNET characteristics: high T2 signal, low T1 signal, and no contrast enhancement. Annual surveillance MRIs from 2014 to 2022 showed no significant changes. However, the 2024 MRI demonstrated lesion progression, with irregular contrast enhancement, in- creased choline, reduced NAA and creatine, and a lactate peak on MR spectroscopy. Diffusion tensor imag- ing (DTI) revealed disruption of white matter tracts, further suggesting atypical behaviour. This concerning and atypical behaviour made us consider the possibility of an initial low-grade-glioma undergoing a malignant transformation. A gross total resection was achieved and histopathological and molecular analyses confirmed a benign DNET without BRAF, IDH1/IDH2 mutations, or MGMT promoter hyper methylation. CONCLUSION This case highlights the diagnostic challenges posed by DNETs with atypical imaging features, including con- trast enhancement and metabolic changes, which can mimic a high-grade transformation. Whilst advanced imaging techniques, such as MR spectroscopy, are critical in monitoring these tumours, this case underscores that current modalities are still not conclusive in defining tumour histology and warrant further radio-genomic research. Surgical resection not only provides definitive diagnosis but also guides long-term management in cases of radiological uncertainty.

Neuro-OncologyVol. 27(Supplement_2)
Queen Elizabeth University Hospital (GB)
Openalex Percentile: Top 74%
Metabolism and Genetic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

UNUSUAL EVOLUTION: PROGRESSIVE DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOUR WITH ATYPICAL CONTRAST ENHANCEMENT AND MR SPECTROSCOPY ABNORMALITIES- A 10-YEAR FOLLOW-UP CASE REPORT — Edward J. St. George, Ahmed Elbelkasy · Neuro-Oncology (2025) | TGRS Research Map | TGRS